Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 14 Sep 2017
At a glance
- Drugs Cannabidiol (Primary)
- Indications Epilepsy
- Focus Expanded access; Therapeutic Use
- 23 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Jan 2018.
- 23 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 11 Jan 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.